Cell-Free Fetal DNA for Prenatal Screening of Aneuploidies and Autosomal Trisomies: A Systematic Review
Conclusion: Cell-free fetal DNA is a reliable screening tool for autosomal trisomies. It is also useful for sex chromosome aneuploidies, although the positive predictive values are lower. A positive screening result should be followed with a confirmatory test.
Saved in:
Main Authors: | Kenza Benchekroun Belabbes (Author), Elena Bendala Tufanisco (Author), Chirag C. Sheth (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis
by: M. Rosario Torres Aguilar, et al.
Published: (2021) -
Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies
by: Jiang Fuman, et al.
Published: (2012) -
Diagnostic value of NIPT assay for fetal aneuploidy screening in pregnant women with moderate risk of trisomy in first stage screening
by: Fatemeh Lalooha, et al.
Published: (2022) -
A contingent model for cell-free DNA testing to detect fetal aneuploidy after first trimester combined screening
by: Carmen Cotarelo-Pérez, et al.
Published: (2019) -
Discordant Prenatal Cell-Free DNA Screening vs. Diagnostic Results of Sex Chromosome Aneuploidies: Implications for Newborn Screening and Genetic Counseling
by: Susan Howell, et al.
Published: (2024)